{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:33:32Z","timestamp":1790472812471,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bjid.2025.104545","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:53:12Z","timestamp":1747201992000},"page":"104545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7956-1606","authenticated-orcid":false,"given":"Jessica","family":"Matuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7052-7735","authenticated-orcid":false,"given":"Daniela Vianna","family":"Pachito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-783X","authenticated-orcid":false,"given":"Filipe","family":"Piastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Cristina Correa","family":"Fehlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-4947","authenticated-orcid":false,"given":"Haliton Alves","family":"de Oliveira Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2025.104545_bib0001","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","article-title":"Ventilator-associated pneumonia in adults: a narrative review","volume":"46","author":"Papazian","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2025.104545_bib0002","unstructured":"ANVISA \u2012 Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Boletim de Seguran\u00e7a do Paciente e Qualidade em Servi\u00e7os de Sa\u00fade n\u00ba 30. 2022."},{"key":"10.1016\/j.bjid.2025.104545_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.37201\/req\/s03.06.2022","article-title":"Current treatment of nosocomial pneumonia and ventilator-associated pneumonia","volume":"35","author":"Plata-Menchaca","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.bjid.2025.104545_bib0004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","article-title":"Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial","volume":"18","author":"Torres","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2025.104545_bib0005","unstructured":"Esicm E.R.S., Alat E., Alat T., et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. n.d.;(July 2017). 10.1183\/13993003.00582-2017."},{"key":"10.1016\/j.bjid.2025.104545_bib0006","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.diagmicrobio.2015.10.008","article-title":"Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae","volume":"85","author":"Martirosov","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2025.104545_bib0007","doi-asserted-by":"crossref","first-page":"ciad428","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104545_bib0008","unstructured":"Pfizer Brasil Ltda. Bula Torgena. 2024."},{"key":"10.1016\/j.bjid.2025.104545_bib0009","unstructured":"World Health Organization - WHO. Antibiotic resistance. 2023."},{"key":"10.1016\/j.bjid.2025.104545_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2025.104545_bib0011","unstructured":"WHO. World Health Organization. Antimicrobial resistance. 2023."},{"key":"10.1016\/j.bjid.2025.104545_bib0012","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. 2019."},{"key":"10.1016\/j.bjid.2025.104545_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.780940","article-title":"Efficacy of Ceftazidime-Avibactam versus Polymyxin B and risk factors affecting clinical outcomes in patients with carbapenem-resistant Klebsiella pneumoniae infections a retrospective study","volume":"12","author":"Fang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.bjid.2025.104545_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.bjid.2025.104545_bib0015","unstructured":"ANVISA \u2012 Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. C\u00e2mara de Regula\u00e7\u00e3o do Mercado de Medicamentos (CMED). 2024."},{"key":"10.1016\/j.bjid.2025.104545_bib0016","article-title":"CBHPM \u2013 Classifica\u00e7\u00e3o Brasileira Hierarquizada de","author":"Associa\u00e7\u00e3o M\u00e9dica","year":"2022","journal-title":"Procedimentos M\u00e9dicos"},{"key":"10.1016\/j.bjid.2025.104545_bib0017","article-title":"Secretaria de Ci\u00eancia T e IE., Departamento de Ci\u00eancia e Tecnologia","author":"Sa\u00fade","year":"2014","journal-title":"Diretrizes Metodol\u00f3gicas Diretriz de Avalia\u00e7\u00e3o Econ\u00f4mica. 2\u00b0 Ed. Bras\u00edlia \u2012 DF"},{"key":"10.1016\/j.bjid.2025.104545_bib0018","series-title":"O uso de limiares de custo-efetividade nas decis\u00f5es em sa\u00fade: recomenda\u00e7\u00f5es da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no SUS","year":"2022"},{"key":"10.1016\/j.bjid.2025.104545_bib0019","series-title":"Semin\u00e1rio de Par\u00e2metros de Avalia\u00e7\u00e3o Econ\u00f4mica no Processo de Atualiza\u00e7\u00e3o do Rol","author":"Ag\u00eancia Nacional de Sa\u00fade","year":"2023"},{"key":"10.1016\/j.bjid.2025.104545_bib0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.clinthera.2020.03.014","article-title":"Cost-effectiveness comparison of Ceftazidime\/Avibactam versus Meropenem in the empirical treatment of hospital-acquired pneumonia, including ventilator-associated pneumonia, in Italy","volume":"42","author":"Tichy","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.bjid.2025.104545_bib0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14737167.2021.1964960","article-title":"Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to carbapenem-resistant Klebsiella pneumoniae in Colombia","volume":"22","author":"Var\u00f3n-Vega","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.bjid.2025.104545_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00897-19","article-title":"Cost-effectiveness of ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia and pneumonia","volume":"63","author":"Simon","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2025.104545_bib0023","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.clinthera.2020.03.014","article-title":"Cost-effectiveness comparison of Ceftazidime\/Avibactam versus Meropenem in the empirical treatment of hospital-acquired pneumonia, including ventilator-associated pneumonia, in Italy","volume":"42","author":"Tichy","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.bjid.2025.104545_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285170","article-title":"The economic burden of antibiotic resistance: a systematic review and meta-analysis","volume":"18","author":"Poudel","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2025.104545_bib0025","unstructured":"ANVISA. Brazilian National Health Surveillance Agency. Antimicrobial Resistance Surveillance Report, 2023. Available at: https:\/\/app.powerbi.com\/view?r=eyJrIjoiOTE3M2RhODAtN2M1Yi00YTc0LWJmMWYtMzNlY2RiZGNlMmNhIiwidCI6ImI2N2FmMjNmLWMzZjMtNGQzNS04MGM3LWI3MDg. n.d."},{"key":"10.1016\/j.bjid.2025.104545_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s41669-022-00368-w","article-title":"Estimating the economic and clinical value of introducing Ceftazidime\/Avibactam into antimicrobial practice in Japan: a dynamic modelling study","volume":"7","author":"Matsumoto","year":"2023","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.bjid.2025.104545_bib0027","doi-asserted-by":"crossref","first-page":"ofx063","DOI":"10.1093\/ofid\/ofx063","article-title":"Carbapenem-resistant Enterobacteriaceae infections: results from a retrospective series and implications for the design of prospective clinical trials","volume":"4","author":"Alexander","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2025.104545_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-Avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2025.104545_bib0029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104545_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijantimicag.2016.07.023","article-title":"Colistin versus polymyxin B for the treatment of patients with multidrug-resistant gram-negative infections: a systematic review and meta-analysis","volume":"49","author":"Vardakas","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2025.104545_bib0031","series-title":"Opem Representa\u00e7\u00e3o Importadora Exportadora e Distribuidora Ltda. Bula Sulfato de polimixina B","year":"2015"},{"key":"10.1016\/j.bjid.2025.104545_bib0032","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/jac\/dkv014","article-title":"Risk factors for nephrotoxicity onset associated with polymyxin B therapy","volume":"70","author":"Dubrovskaya","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2025.104545_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinf.2012.01.015","article-title":"Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy","volume":"65","author":"Kubin","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2025.104545_bib0034","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/2175-8239-jbn-2019-0234","article-title":"Brazilian Dialysis Census: analysis of data from the 2009-2018 decade","volume":"42","author":"Neves","year":"2020","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.bjid.2025.104545_bib0035","series-title":"Geografia e Estat\u00edstica","author":"Instituto Brasileiro de","year":"2021"},{"key":"10.1016\/j.bjid.2025.104545_bib0036","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-122-7-199504010-00007","article-title":"Health values of the seriously ill. SUPPORT investigators","volume":"122","author":"Tsevat","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bjid.2025.104545_bib0037","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1524-4733.2007.00308.x","article-title":"Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis","volume":"11","author":"Liem","year":"2008","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.bjid.2025.104545_bib0038","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"issue":"spec","key":"10.1016\/j.bjid.2025.104545_bib0039","first-page":"1","article-title":"Custos das di\u00e1rias de unidade de terapia intensiva no Sistema \u00danico de Sa\u00fade na COVID-19","volume":"12","author":"Carlos","year":"2021","journal-title":"JMPHC | J Manag Prim Heal Care"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:59:42Z","timestamp":1762545582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867025000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1413867025000467"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104545","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104545"}}